Venture Capital Access

print

Venture Capital Access

BioInvestments


Our company is uniquely positioned to analyze business plans and valuations to identify products that could be of investment interest to individual high net worth investors. Additionally, the company has access to seed step angel organizations that provide a strategic fit for some startup ventures.


0


Overview

Companies at all stages of development require access to capital. Our organization has a separate company specifically developed to review and analyze venture capital request. This company is composed of experienced investment bankers and executives with demonstrated biological company operations experience. This company is uniquely positioned to analyze business plans and valuations to identify products that could be of investment interest to individual high net worth investors. Additionally, the company has access to seed step angel organizations that provide a strategic fit for some startup ventures.

Customize

Funding Time
N/A 1 Month 2 Months 3 Months 9 Months 1 Year

Type of Funding
N/A Angel Seed Funding Venture Capital

Venture Capital Investment Stage
N/A Round 1/A Round 2/B Round 3/C

Funding Goal
N/A $1-$100K $100K-$250K $250K-$500K Above $500K

Technology Stage
N/A Concept Product Definition Product Development Product Trials Commercialization Expansion

Known Valuation
N/A Less than $500K Between $1M and $2M Between $2M and $5M Above $5M

Return Options
N/A Equity Stock Either

COLLECT:

Custom collections from a pool of thousands of healthy donors.

CHARACTERIZE:

Flowcytometry characterization of immune cells.

ISOLATE:

Research or GMP grade positive or negative cell selection procedures.

EXPAND:

Flask or automated expansion services.

FREEZE:

Controlled rate freezing using custom cryo-preservatives.

STORE:

Monitored LN2 vapor phase storage of products and samples.